News | September 03, 2014

Future Cardiovascular CT Advances to Watch

As technology continues to advance for all diagnostic imaging modalities, it sometimes reminds me of a race between vendors to build a better mouse trap. The main issue between cardiac echo, computed tomography (CT), magnetic resonance imaging (MRI), nuclear (SPECT and PET) and invasive angiography is that each has its strengths and weaknesses. When one test falls short, another is used to add diagnostic information, but it also adds time and cost. Unfortunately, in this era of cutting costs and bundled payments, the holy grail of medical imaging would be a one-stop shop cardiac imaging test that combines the majority of the key assets of each of these modalities.

I attended the Society of Cardiovascular Computed Tomography (SCCT) annual meeting in July, where both cardiologists and radiologists came together to make a case for why CT will become the primary cardiac imaging test in coming years. It showed CT radiation is declining and new technology can bring cardiac CT doses below 1 mSv, which is key to CT’s wider acceptance. Data from several trials demonstrate the viability of CT to accurately show myocardial perfusion and fractional flow reserve (FFR) data for the entire coronary tree from a single scan. Work is also continuing to improve plaque characterization software to bring it on par with invasive catheter-based virtual histology intravascular ultrasound (VH-IVUS) or spectrographic plaque analysis. Additionally, spectral CT imaging may enable a new way to image chemical makeup of tissue and allow new types of contrast media. 

Speakers at SCCT discussed the use of gold nanoparticles with a polyethylene glycol (PEG) coating, or tantalum, as replacement agents for iodine blood imaging; bromide and fluorine with a phospholipid coating to image liver tumors; and iodine-loaded or bismuth nanoparticles with a biomarker to target fibrin to clearly image blood clots. Nanoparticles may also boost the ability of iodine as a contrast agent. By coating iodine inside liposome particles, the outer shell will protect the iodine from breaking down immediately, both extending its imaging half-life and possibly aiding renal clearance over a longer period of time to reduce contrast-induced nephropathy (CIN). 

New types of contrast, especially if combined with spectral CT, may enable inflammation and macrophage imaging, both components of vulnerable plaque. If validated, this new way to image vulnerable plaques prior to rupture might offer a novel way to determine heart attack risk and possibly identify lesions to stent before a heart attack occurs.  

To read more on these and other cardiac CT advances, see the article from the September-October 2014 issue of DAIC. 

Watch a video interview regarding these advances in cardiac CT.

Related Content

Houston Methodist Hospital Enters Multi-Year Technology and Research Agreement With Siemens Healthineers
News | Cardiac Imaging| August 17, 2017
Houston Methodist Hospital and Siemens Healthineers have entered into a multi-year agreement to bring cutting-edge...
Four Blue Cross Blue Shield Companies Issue Positive Medical Policies on HeartFlow FFRct Analysis
News | FFR Catheters| August 09, 2017
HeartFlow Inc. announced that four Blue Cross Blue Shield companies have each issued a positive medical policy for the...
3D printing of the heart and coronary artery tree from a patient's CT scan.
Sponsored Content | Webinar | 3-D Printing| August 09, 2017
Learn how 3-D printing empowers medical device manufacturer Medtronic to bring products to market faster, develop bet
Moffitt Cancer Center Enhances Patient Care with Toshiba Medical's Infinix-i 4-D
News | Interventional Radiology| August 03, 2017
Cancer patients at Moffitt Cancer Center in Tampa, Fla., now have access to advanced diagnostic imaging for fast and...
Philips released a new version of its iFR system that displays FFR readings as an overlay on live angiographic, angiogram images.

Philips released a new version of its iFR system that displays hemodynamic pressure drop points in an overlay on live angiographic images, matching up the iFR readings with corresponding lesions. The system is supposed to speed diagnostic decision making and help guide percutaneous revascularization procedures. 

Feature | FFR Catheters| July 31, 2017 | Dave Fornell
The gold standard for assessing the hemodynamic significance of coronary lesions to determine if they should be revas
New York Hospital Finds Significant Cost Savings With Toshiba's Aquilion One CT
News | Computed Tomography (CT)| July 25, 2017
July 25, 2017 — In five years, Kaleida Health’s Stroke Care Center (SCC) at the Gates Vascular Institute in Buffalo,
Samsung Introduces FDA-Cleared BodyTom Elite CT Scanner
Technology | Computed Tomography (CT)| July 24, 2017
Samsung announced U.S. Food and Drug Administration (FDA) approval of the BodyTom Elite, an upgraded version of its...
Sponsored Content | Videos | CT Angiography (CTA)| July 21, 2017
DAIC and ITN Editor Dave Fornell discusses some of the most innovative new computed tomography (CT) technology and tr
Cardiac CT scan showing plaque and calcification in the coronary arteries, from a Toshiba CT scanner
News | Business| July 19, 2017
July 19, 2017 — The Society of Cardiovascular Computed Tomography (SCCT) created a reimbursement fee chart for cardia
Sponsored Content | Videos | Cardiac Imaging| July 18, 2017
Leslee Shaw, Ph.D., director of clinical research and professor of medicine at Emory University, Atlanta, and past-pr
Overlay Init